MedPath

Feasibility study of Neoadjuvant chemoradiotherapy for locally advanced esophageal carcinoma

Phase 2
Conditions
Esophageal Cancer
Registration Number
JPRN-UMIN000004223
Lead Sponsor
ational Cancer Center Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)active other malignancies within 5 years 2)Pregnant or lactating women, women who are capable of pregnancy or intend to get pregnant, men who don't intend to have protected intercourse. 3)Unsuitable mental status and condition for clinical trials. 4)Patients who received ontinuous steroids (orally or intravenous) administration. 5)Positive HBsAg. 6)Unstable diabetes mellitus with oral hypoglycemic agent or insulin. 7)Acute myocardial infarction within 3 months 8)severe complications (COPD, interstitial lung disease, pulmonary fibrosis, heart failure and so on) 9)clinically significant infectious disease(body temperature less than 38.0 degrees) 10)Any other cases who are regarded as inadequate for study enrollment by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Completion proportion of curative surgery
Secondary Outcome Measures
NameTimeMethod
Overall survival, Progression free survival, curative resection rate, Response rate for CRT Pathological CR rate Acute toxicity Late toxicity Surgical toxicity
© Copyright 2025. All Rights Reserved by MedPath